Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-01 | Future report Set alerts | |
Q2 2022 | 2022-07-27 | 0.52 | 0.52 |
Q1 2022 | 2022-04-27 | 0.47 | 0.47 |
Q4 2021 | 2022-02-16 | 0.49 | 0.49 |
Q3 2021 | 2021-11-03 | 0.65 | 0.65 |
Q2 2021 | 2021-07-27 | 0.80 | 0.80 |
Q1 2021 | 2021-04-28 | 0.20 | 0.20 |
Q4 2020 | 2021-02-17 | -0.32 | -0.32 |
Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
Q2 2020 | 2020-07-29 | -0.87 | -1.61 |
2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-01 | Reiterated Rating | Stephens | Overweight | $58.00 |
2016-04-28 | Reiterated Rating | Jefferies Group | Hold | $52.00 |
2016-04-28 | Reiterated Rating | Oppenheimer | Hold | |
2016-04-28 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
2016-04-01 | Reiterated Rating | Maxim Group | Buy | $57.00 |
2016-03-31 | Reiterated Rating | JPMorgan Chase & Co. | Hold | $55.00 |
2016-03-31 | Reiterated Rating | S&P Equity Research | Hold | $53.00 |
2016-03-31 | Reiterated Rating | Guggenheim | Hold | |
2016-03-31 | Reiterated Rating | Jefferies Group | Hold | $52.00 |
2016-03-31 | Reiterated Rating | Wells Fargo | Hold | |
2016-03-31 | Reiterated Rating | Telsey Advisory Group | Hold | $56.00 |
2016-03-31 | Reiterated Rating | Morgan Stanley | Hold | $53.00 |
2016-03-31 | Reiterated Rating | William Blair | Buy | |
2016-03-31 | Reiterated Rating | Stephens | Buy | $58.00 |
2016-03-31 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-03-31 | Reiterated Rating | Wells Fargo & Co. | Hold | |
2016-02-20 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-02-20 | Reiterated Rating | Robert W. Baird | Neutral | |
2016-02-20 | Reiterated Rating | BTIG Research | Buy | $60.00 |
2016-02-17 | Reiterated Rating | Oppenheimer | Market Perform | |
2016-02-17 | Lower Price Target | Piper Jaffray | Overweight | $62.00 to $57.00 |
2016-02-17 | Boost Price Target | Telsey Advisory Group | Market Perform | $55.00 to $56.00 |
2016-02-17 | Lower Price Target | Piper Jaffray Cos. | Overweight | $62.00 to $57.00 |
2016-02-09 | Initiated Coverage | Maxim Group | Buy | $57.00 |
2016-01-27 | Upgrade | Stephens | Equal Weight to Overweight | $58.00 |
2015-11-25 | Reiterated Rating | William Blair | Outperform | |
2015-11-02 | Boost Price Target | Robert W. Baird | Neutral | $45.00 to $52.00 |
2015-10-27 | Reiterated Rating | Piper Jaffray | Buy | |
2015-10-27 | Reiterated Rating | Oppenheimer | Hold | |
2015-10-27 | Lower Price Target | Jefferies Group | Hold | $53.00 to $52.00 |
2015-10-27 | Reiterated Rating | Barclays | Equal Weight | $57.00 to $53.00 |
2015-10-27 | Lower Price Target | Stifel Nicolaus | Buy | $70.00 to $65.00 |
2015-10-27 | Upgrade | BTIG Research | Neutral to Buy | $60.00 |
2015-10-27 | Lower Price Target | Telsey Advisory Group | Market Perform | $60.00 to $55.00 |
2015-10-27 | Reiterated Rating | Barclays PLC | Equal Weight | $57.00 to $53.00 |
2015-10-17 | Reiterated Rating | Barclays | Equal Weight | $57.00 |
2015-09-29 | Initiated Coverage | Telsey Advisory Group | Market Perform | $60.00 |
2015-07-23 | Reiterated Rating | Jefferies Group | Hold | $51.00 to $53.00 |
2015-07-23 | Boost Price Target | Robert W. Baird | Neutral | $54.00 to $58.00 |
2015-07-23 | Boost Price Target | Piper Jaffray | Overweight | $55.00 to $62.00 |
2015-07-23 | Boost Price Target | Barclays | Equal Weight | $54.00 to $57.00 |
2015-07-23 | Reiterated Rating | Stifel Nicolaus | Buy | $65.00 to $70.00 |
2015-07-23 | Reiterated Rating | Wunderlich | Hold | $58.00 to $60.00 |
2015-07-15 | Initiated Coverage | BTIG Research | Neutral | |
2015-07-01 | Initiated Coverage | Goldman Sachs | Sell | $51.00 |
2015-07-01 | Initiated Coverage | Goldman Sachs Group Inc. | Sell | $51.00 |
2015-05-28 | Reiterated Rating | Wunderlich | Hold | $58.00 |
2015-05-21 | Boost Price Target | Miller Tabak | Buy | $55.00 to $58.00 |
2015-04-23 | Boost Price Target | Piper Jaffray | Overweight | $53.00 to $55.00 |
2015-04-23 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $47.00 to $51.00 |
2015-04-23 | Reiterated Rating | Jefferies Group | Neutral to Hold | $45.00 to $51.00 |
2015-04-23 | Boost Price Target | Barclays | Equal Weight | $50.00 to $54.00 |
2015-04-23 | Boost Price Target | Stifel Nicolaus | Buy | $60.00 to $65.00 |
2015-04-23 | Reiterated Rating | Wunderlich | Hold | $50.00 to $58.00 |
2015-04-23 | Reiterated Rating | Telsey Advisory Group | Market Perform | $50.00 to $53.00 |
2015-04-15 | Initiated Coverage | Guggenheim | Neutral | |
2015-03-05 | Downgrade | Argus | Buy to Hold | |
2015-02-12 | Set Price Target | Morgan Stanley | Hold | $45.00 |
2015-02-12 | Set Price Target | Jefferies Group | Hold | $50.00 to $45.00 |
2015-02-12 | Set Price Target | Barclays | Hold | $53.00 to $50.00 |
2015-02-12 | Downgrade | Stephens | Overweight to Equal Weight | |
2015-02-12 | Lower Price Target | Stifel Nicolaus | Buy | $65.00 to $60.00 |
2015-02-12 | Downgrade | Sterne Agee CRT | Buy to Neutral | |
2015-02-12 | Boost Price Target | Wunderlich | Hold | $46.00 to $50.00 |
2015-02-12 | Lower Price Target | Miller Tabak | Positive to Buy | $56.00 to $55.00 |
2015-02-12 | Lower Price Target | Telsey Advisory Group | Market Perform | $55.00 to $50.00 |
2015-01-20 | Upgrade | William Blair | Market Perform to Outperform | |
2015-01-16 | Upgrade | Bank of America | Underperform to Neutral | |
2015-01-16 | Upgrade | Bank of America Corp. | Underperform to Neutral | |
2015-01-07 | Upgrade | Bank of America | Underperform to Neutral | $53.00 |
2015-01-06 | Reiterated Rating | Jefferies Group | Hold | $43.00 to $50.00 |
2014-10-23 | Reiterated Rating | Stifel Nicolaus | Buy | $58.00 to $56.00 |
2014-10-23 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $47.00 to $48.00 |
2014-10-23 | Reiterated Rating | Barclays | Equal Weight | $49.00 to $45.00 |
2014-10-23 | Reiterated Rating | Wunderlich | Equal Weight | $46.00 to $42.00 |
2014-10-01 | Initiated Coverage | Stifel Nicolaus | Buy | |
2014-08-21 | Downgrade | Bank of America | Buy to Underperform | $50.00 to $42.00 |
2014-07-31 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $50.00 to $47.00 |
2014-07-24 | Reiterated Rating | Jefferies Group | Hold | $46.00 to $43.00 |
2014-07-24 | Reiterated Rating | Wunderlich | Hold | $48.00 to $46.00 |
2014-05-07 | Reiterated Rating | Wunderlich | Buy | $46.00 to $48.00 |
2014-05-02 | Initiated | Gabelli & Co | Hold | $53 |
2014-05-02 | Initiated Coverage | Gabelli | Hold | $53.00 |
2014-04-24 | Lower Price Target | Telsey Advisory Group | Not Rated | $55.00 to $52.00 |
2014-04-24 | Reiterated Rating | Credit Suisse | Outperform | $58.00 |
2014-04-15 | Boost Price Target | Barclays | Equal Weight | $45.00 to $54.00 |
2014-04-10 | Upgrade | Tigress Financial | Neutral to Buy | |
2014-02-13 | Boost Price Target | Susquehanna | $41.00 to $42.00 | |
2014-02-13 | Lower Price Target | Jefferies Group | $47.00 to $46.00 | |
2014-02-10 | Upgrade | Ned Davis Research | Neutral to Buy | |
2014-01-09 | Initiated Coverage | Buckingham Research | Buy | |
2014-01-07 | Initiated Coverage | Credit Suisse | Outperform | |
2013-11-26 | Boost Price Target | Jefferies Group | $40.00 to $47.00 | |
2013-10-24 | Boost Price Target | Lazard Capital Markets | Buy | $50.00 to $53.00 |
2013-10-24 | Boost Price Target | Jefferies Group | Hold | $40.00 |
2013-07-16 | Reiterated | Argus | Buy | $46 to $52 |
2013-06-17 | Reiterated | Miller Tabak | Buy | $42 to $45 |
2013-04-25 | Reiterated | RBC Capital Mkts | Sector Perform | $37 to $43 |
2013-04-15 | Reiterated | Miller Tabak | Buy | $39 to $42 |
2011-07-21 | Reiterated | RBC Capital Mkts | Sector Perform | $31 to $35 |
2011-04-21 | Reiterated | Barclays Capital | Equal Weight | $28 to $33 |
2011-01-25 | Upgrade | Miller Tabak | Hold to Buy | $35 |
2010-10-22 | Reiterated | Barclays Capital | Equal Weight | $28 to $29 |
2010-07-13 | Upgrade | MKM Partners | Neutral to Buy |
2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-01 | Reiterated Rating | Stephens | Overweight | $58.00 |
2016-04-28 | Reiterated Rating | Jefferies Group | Hold | $52.00 |
2016-04-28 | Reiterated Rating | Oppenheimer | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CAKE 196 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 8.44M |
Vanguard Group, Inc | 5.41M |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 4.02M |
BAMCO INC /NY/ | 3.01M |
BlackRock Fund Advisors | 2.62M |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2.37M |
WESTFIELD CAPITAL MANAGEMENT CO LP | 1.91M |
STATE STREET CORP | 1.75M |
FRED ALGER MANAGEMENT INC | 1.52M |
BlackRock Institutional Trust Company, N.A. | 1.45M |
Invesco Ltd. | 1.15M |
DIMENSIONAL FUND ADVISORS LP | 1.11M |
GEODE CAPITAL MANAGEMENT, LLC | 0.89M |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 0.60M |
CITADEL ADVISORS LLC | 0.57M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
OVERTON DAVID Chairman and C.E.O. | 5.78% (2864760) | CAKE / |
SIMON HERBERT | 0.39% (195000) | CAKE / SPG / |
BENN DOUG Exec VP, CFO | 0.11% (53360) | CAKE / |
ZURZOLO DEBBY R Exec VP, Gen Counsel & Secy | 0.05% (27242) | CAKE / |
KRANSDORF JEROME I | 0.03% (13750) | CAKE / |
SLOMANN CHERYL Principal Accounting Officer | 0.03% (12528) | CAKE / |
PITTAWAY DAVID BRUCE | 0.02% (12122) | BBRG / CAKE / |
MINDEL LAURENCE B | 0.01% (5000) | CAKE / |
CAPPELLO ALEXANDER L | 0.01% (4790) | CAKE / VIRC / |
Gordon David M President | 0.01% (4680) | CAKE / |
Schmick Douglas L | 0.01% (4505) | CAKE / CHUY / |
Clark Matthew Eliot VP, Strategic Planning | 0.01% (3803) | CAKE / |